Clinical Trial Update: A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two treatments in newly diagnosed multiple myeloma patients ineligible for transplant is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Multiple Myeloma, New Diagnosis Tumor | Phase 3 | Status: ACTIVE_NOT_RECRUITING